FCDO Research, Science and Technology

@FCDOGovUK 🇬🇧 Foreign Commonwealth & Development Office Science, Technology, Research and Evidence ⚡️ 🔭 🤖💉🦠🌽 🧬🌍

[Global Research and Technology Development @GRTDnews]

The UK’s new MHRN strengthens global prevention, preparedness & response to outbreaks & multi-hazard crises through rapid expert advice.
Led by IDS, it is already supporting Ebola response in DRC & Uganda, alongside £5m for new treatments & diagnostics.
🔗 https://t.co/ZbGe06PQEu

[UK in DRC @UKinDRC]

Le Royaume-Uni vient de lancer un nouveau réseau de recherche multi-risques, réunissant des experts afin de renforcer la prévention, la preparation et la réponse aux épidémies, y compris l’Ebola en RDC.

https://t.co/7i8b4vWS7S

[UK in DRC @UKinDRC]

La semaine dernière en RDC, @JennyChapman a vu le travail accompli par des partenaires pour contenir l’épidémie d’Ebola et protéger les communautés.
L’ampleur du défi ne doit pas être sous-estimée. Le Royaume-Uni continuera de soutenir une riposte menée par les pays africains.

[Global Research and Technology Development @GRTDnews]

📢 Call for Applications: Eleven Senior Research Fellowships
Hosted by FCDO in London or East Kilbride, these two-year placements are 0.4 FTE and subject to Security Check clearance.
Applications close 30 August 2026, 5pm GMT.
Apply: https://t.co/fHfsMtkNOY

[Jenny Chapman @JennyChapman]

The only way we are going to tackle the global challenges of today is through partnerships.

We must draw on the strengths that everyone has to offer.

That is how we build a better future.

Read my speech at the Global Partnerships Conference here ⤵️

https://t.co/A8iVbzkjFL

[Foreign, Commonwealth & Development Office @FCDOGovUK]

Watch the Global Partnerships Conference livestream on YouTube here ⤵️

https://t.co/65b4adNBKJ

[Jenny Chapman @JennyChapman]

The world has changed.

But our values, ambition and determination to build a safer, fairer and more prosperous world, remains stronger than ever.

To achieve this ambition, the way we work together must change too.

https://t.co/i8UyWTgFeY

[Wellcome @wellcometrust]

Just over one month left to apply for infectious disease clinical trial funding. ⏰

We’re supporting transdisciplinary teams led from Africa, South Asia or South-East Asia to run randomised controlled trials that optimise licensed vaccines and therapeutics for infectious diseases.

The goal: generate evidence that can inform changes to policy, practice or guidelines – and improve prevention and treatment in the communities most affected.

• Level: £1,000,000 – £8,000,000 per award.
• Duration: 3 – 5 years
• Deadline: 2 June 2026

Delivered in partnership with NIHR:
https://t.co/dIOFenR4y1

[Medicines for Malaria Venture (MMV) @MedsforMalaria]

British-backed science has helped build today’s antimalarial toolbox. Sustained support can get us closer to #ZeroMalaria.

UK Parliamentarians explored tools behind progress against #malaria and innovations that can define what’s next at @malarianomoreuk’s #WorldMalariaDay event

[Foreign, Commonwealth & Development Office @FCDOGovUK]

Today, the UK set out new innovative development reforms – ensuring every pound delivers for the UK taxpayer and the people we support.

[FCDO Procurement @FCDOProcurement]

Preliminary Market Engagement Notice: Jobs and Inclusive Growth Centre of Expertise - Technical Assistance Facility. Thursday 26th March 26. Access https://t.co/KMV9D6qp68 or the QR code below for more information on this opportunity. #FCDOGovUK #UKAid

[National Institute for Health and Care Research @NIHRresearch]

@DHSCgovuk (through NIHR), @FCDOGovUK and @wellcometrust
are funding clinical trials led by researchers in Africa, South and South-East Asia!

🔷 Focus: high-burden infectious diseases.
🔷Awards £1–8m.

Find out more ➡️ https://t.co/macFKjW6cx
#GlobalHealth #ClinicalTrials

[Wellcome @wellcometrust]

New funding for infectious disease clinical trials! 📣 

We’re funding randomised controlled trials to optimise existing vaccines and therapeutics for infectious diseases.

This research must be led by those closest to the challenge. The lead applicant must be based in a low- or middle-income country in Africa, South Asia, or South-East Asia.

Trials should focus on one of the following disease areas:
• mycobacterial infections (tuberculosis, leprosy or infections with non-tuberculous mycobacteria)
• bacterial infections (sexually transmitted infections, lower respiratory tract infections or bloodstream infections)
• invasive fungal infections
• dengue, leishmaniasis or schistosomiasis

If you have an innovative idea for a randomised controlled trial proposal, but need to build your team, develop your clinical trial protocol or generate pilot data, you can apply to our Infectious Disease Clinical Trial Development Award.

Delivered in partnership with @NIHRresearch and @FCDOResearch

Learn more about eligibility and how to apply ⤵️
https://t.co/r4NSMiICJK

[Drugs for Neglected Diseases initiative @DNDi]

@sanofi @EMA_News 🤝 This achievement reflects over a decade of collaboration and innovation across the global health community.

We thank our partners, donors, staff & everyone who was involved in making the dream of a single-dose, oral treatment for sleeping sickness come true.

[Drugs for Neglected Diseases initiative @DNDi]

🚀 Huge news for people living with #sleepingsickness!

Acoziborole, a one-day, single-dose oral treatment developed with @sanofi, has received a positive opinion from @EMA_News for the treatment of the most common form of sleeping sickness.

👉https://t.co/4OQt1ISllv #beatNTDs

[Community Jameel @CommunityJameel]

At the @OfficialINDIAai Impact Summit, we are joining partners investing in evidence to guide governments, donors and NGOs in funding and scaling up AI where it has the greatest potential to maximise social good.

AI for Social Good.

@JPAL @FCDOResearch @GoogleDeepMind

[Medicines for Malaria Venture (MMV) @MedsforMalaria]

Long-term investment in #malaria innovation pays off in measurable ways. A @LancetGH study (2000-2023) finds investments in MMV deliver 13× their value in health benefits. See why PDPs like MMV offer a proven model for global health investment: https://t.co/0axwkc3A1f

[Wilton Park @WiltonPark]

🌍 How can we better include learners with disabilities in mainstream education?

Our dialogue builds on the 2025 @GDS_Disability to share evidence and develop a roadmap for turning research into action.

🤝 @IDA_CRPD_Forum I @LSHTM I @FCDOGovUK

🔗 https://t.co/JyzHUjL5Rh

[SEI Africa @SEI_Africa]

📢 Funding opportunity!

Raising Adaptation Impact and Ambition (RAIA) is inviting funding proposals to support research on the economics of climate change adaptation in Africa.

Call info session:https://t.co/JgeVibUoNs

✍️Apply:https://t.co/OT7VEJewBK

@UNEP @FCDOResearch

[Government Office for Science @uksciencechief]

Happy @UN International Day of Women and Girls in Science. Celebrating the curiosity, talent and leadership of women across science, engineering and technology. #WomenInScience #GirlsInScience #11February #CelebratingScienceAdvice #WomenInSTEM